VANARIX
Vanarix is a swiss clinical-stage company that focuses on articular cartilage regeneration.
VANARIX
Social Links:
Industry:
Health Care Medical
Founded:
2018-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.vanarix-cartilage-regeneration.ch
Total Employee:
1+
Status:
Active
Total Funding:
4 M CHF
Similar Organizations
DK MedTech
Dingke Medical is a medical device tech firm specializing in the R&D and production of vascular interventional medical treatment products.
Current Employees Featured
Founder
Official Site Inspections
http://www.vanarix-cartilage-regeneration.ch
- Host name: studio2.serveur-dedie.fr
- IP address: 91.212.205.202
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Vanarix"
Cartibeads bio-engineered cartilage grafts
Vanarix develops cartilage regeneration, the first autologous hyaline cartilage microtissues of high quality, designed for everyone whatever your age. We offer a new technology to treat cartilage lesions. We have developed and recently …See details»
Overview of Vanarix’s collaborations and timeline to Geneve
The company has developed and patented an innovative advanced cell therapy medical product to repair cartilage defects. In 2022, a First-In-Man study (phase I/IIa) with Autologous …See details»
Vanarix SA - BioAlps
Avenue de Sécheron 15 1202 Geneva, Switzerland T +41 22 545 12 91. c/o BIOPÔLE SA Secteur Esplanade / Bâtiment Serine Route de la Corniche 8 1066 Epalinges, SwitzerlandSee details»
Vanarix - Crunchbase Company Profile & Funding
Cartibeads are engineered autologous hyaline cartilage microtissues designed to repair cartilage defects by using chondrocytes to synthesize a hyaline matrix, offering a potential treatment for …See details»
Une spin-off de l’UNIGE régénère les cartilages abîmés
Le processus unique breveté par Vanarix se déroule en trois temps – déspécialisation – multiplication des cellules à volonté – respécialisation et repousse du cartilage. Grâce à cette …See details»
Vanarix raises CHF 4 million to advance cartilage regeneration
Jul 15, 2024 Biopôle-based start-up Vanarix has secured CHF 4 million to initiate new clinical trials and automate the manufacturing of its Cartibeads. Founded in 2018, Vanarix is a …See details»
Vanarix SA • Biopôle • Switzerland
Vanarix is a clinical stage start-up company specializing in regenerative medicine. Vanarix’s mission is to develop innovative and effective cell-based therapies that address unmet medical …See details»
Vanarix raised CHF 4 Million to begin new clinical trials
Dec 9, 2024 Founded in 2018, Vanarix is a clinical stage startup specialising in regenerative medicine, focusing on articular cartilage regeneration. Despite being a small team of three …See details»
Overview of Vanarix’s collaborations and timeline to Geneve
Vanarix was founded in 2018. Headquarted in Lausanne, Switzerland. The company has a research group working at the faculty of medicine in Geneva strategically located near …See details»
First successful transplantation for Vanarix - Biopôle
Vanarix has developed a new generation of cell therapy to produce high quality hyaline cartilage microtissues named Cartibeads, resembling native tissue. Cartibeads can be transplanted …See details»
Vanarix Company Profile 2024: Valuation, Funding & Investors
Vanarix General Information Description. Operator of a medical research company intended to create hyaline cartilage mini-grafts. The company's product can be integrated into cartilage …See details»
Vanarix lève CHF 4M en faveur de la régénération du cartilage
Jul 15, 2024 Basée au Biopôle, la start-up Vanarix a levé CHF 4 millions pour lancer de nouveaux essais cliniques et automatiser la fabrication de ses Cartibeads. Fondée en 2018, …See details»
Vanarix: The Venture Leader Biotech regenerating tissue to treat ...
Jul 9, 2022 The therapeutic indications are the treatment of articular cartilage defects found in focal cartilage lesions but also in early osteoarthritis. Indeed, more than 80% of orthopedic …See details»
Vanarix SA - startup.ch
Vanarix SA: Repairing damaged articular cartilage is still an unmet medical need. Cartilage damage causes pain and disability and affects people with repetitive trauma, elderly and …See details»
Pipeline research and development preclinical clinical
At present, a First-In-Man study is underway to treat knee cartilage lesions using Allogeneic Cartibeads™ (derived from donor cells). Recruitment is expected to be completed in 2024, …See details»
Vanarix SA - Venturelab
Sep 7, 2018 A cartilage regeneration company in clinical phase Vanarix SA. Incorprated 09.07.2018. Headquarters Lausanne. Support. Repairing damaged articular cartilage is still an …See details»
Vanarix SA - Swiss Biotech
As a Swiss Biotech Association member, you profit from our engagement with national and international stakeholders, receive privileged information, share knowledge, improve your …See details»
Cartilage regeneration Cartibeads autologous hyaline microtissues
Vanarix develops cartilage regeneration, the first autologous hyaline cartilage microtissues of high quality, designed for everyone whatever your age. We offer a new technology to treat cartilage …See details»
Funding Round - Vanarix - 2024-07-10 - Crunchbase
Jul 10, 2024 Vanarix raised $4448260 on 2024-07-10 in Funding Round. Search Crunchbase. ... startupticker.ch — CHF 4M and new clinical trials for ... 2024. Greater Geneva Bern area — …See details»